Follow
Maria Farooq
Maria Farooq
Verified email at nih.gov
Title
Cited by
Cited by
Year
Personalized circulating tumor DNA analysis to detect residual disease after neoadjuvant therapy in breast cancer
BR McDonald, T Contente-Cuomo, SJ Sammut, A Odenheimer-Bergman, ...
Science translational medicine 11 (504), eaax7392, 2019
2362019
Evaluation of pre-analytical factors affecting plasma DNA analysis
H Markus, T Contente-Cuomo, M Farooq, WS Liang, MJ Borad, ...
Scientific reports 8 (1), 7375, 2018
1272018
Effect of species and harvest maturity on the fatty acids profile of tropical forages
NA Khan, MW Farooq, M Ali, M Suleman, N Ahmad, SM Sulaiman, ...
The JAPS 25 (3), 739-746, 2015
552015
Abstract P4-01-21: Multiplexed targeted digital sequencing of circulating tumor DNA to detect minimal residual disease in early and locally advanced breast cancer
BR McDonald, T Contente-Cuomo, SJ Sammut, B Ernst, ...
Cancer Research 79 (4_Supplement), P4-01-21-P4-01-21, 2019
502019
Noninvasive diagnostics for early detection of lung cancer: challenges and potential with a focus on changes in DNA methylation
M Farooq, JG Herman
Cancer Epidemiology, Biomarkers & Prevention 29 (12), 2416-2422, 2020
202020
Genome-wide analysis of aberrant position and sequence of plasma DNA fragment ends in patients with cancer
KK Budhraja, BR McDonald, MD Stephens, T Contente-Cuomo, H Markus, ...
Science translational medicine 15 (678), eabm6863, 2023
162023
Anaerobic respiration: In vitro efficacy of Nitazoxanide against mitochondriate Acanthamoeba castellanii of the T4 genotype
Y Aqeel, R Siddiqui, M Farooq, NA Khan
Experimental parasitology 157, 170-176, 2015
102015
Personalized circulating tumor dna analysis to detect residual disease after neoadjuvant therapy in breast cancer. Sci Transl Med 11: eaax7392
BR McDonald, T Contente-Cuomo, SJ Sammut, A Odenheimer-Bergman, ...
72019
Analysis of fragment ends in plasma DNA from patients with cancer
KK Budhraja, BR McDonald, MD Stephens, T Contente-Cuomo, H Markus, ...
medRxiv, 2021.04. 23.21255935, 2021
62021
Detection of copy number aberrations in cholangiocarcinoma using shallow whole genome sequencing of plasma DNA.
M Farooq, JB Egan, B McDonald, H Markus, T Contente-Cuomo, ...
Journal of Clinical Oncology 36 (4_suppl), 293-293, 2018
42018
Evaluation of pre-analytical factors affecting plasma DNA analysis. Sci Rep. 2018; 8: 7375
H Markus, T Contente-Cuomo, M Farooq, WS Liang, MJ Borad, ...
3
Blood-based multi-cancer detection: A state-of-the-art update
M Farooq, E Leevan, J Ahmed, B Ko, S Shin, A De Souza, N Takebe
Current Problems in Cancer 48, 101059, 2024
12024
Trends in disparities in clinical trial accrual: An analysis of National Cancer Institute (NCI)-sponsored early phase clinical trials over the last 22 years
M Farooq, E Sharon, N Takebe, AF Best, S Finnigan
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION 32 (12), 2023
2023
Abstract B036: Trends in disparities in clinical trial accrual: An analysis of National Cancer Institute (NCI)-sponsored early phase clinical trials over the last 22 years
M Farooq, E Sharon, N Takebe, AF Best, S Finnigan
Cancer Epidemiology, Biomarkers & Prevention 32 (12_Supplement), B036-B036, 2023
2023
Detection of FGFR fusions in intrahepatic cholangiocarcinoma using targeted RNA sequencing.
M Farooq, H Markus, B McDonald, JB Egan, T Contente-Cuomo, ...
Journal of Clinical Oncology 39 (15_suppl), e16185-e16185, 2021
2021
Personalized monitoring of treatment response using Targeted Digital Sequencing of circulating tumor DNA
BR McDonald, T Contente-Cuomo, SJ Sammut, MD Stephens, ...
CLINICAL CANCER RESEARCH 26 (11), 61-61, 2020
2020
Abstract A51: Personalized monitoring of treatment response using Targeted Digital Sequencing of circulating tumor DNA
BR McDonald, T Contente-Cuomo, SJ Sammut, MD Stephens, ...
Clinical Cancer Research 26 (11_Supplement), A51-A51, 2020
2020
Circulating Tumor DNA Analysis and Opportunities for Personalized Cancer Medicine
M Farooq, M Murtaza
Companion and Complementary Diagnostics, 229-242, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–18